What is Illumina's market cap?

Illumina (ILMN) has a market capitalization of $25.70B as of June 15, 2026. Market cap is the total market value of the company's outstanding shares (share price × shares outstanding), shown here in US dollars (USD).

How is Illumina's market cap calculated, and what currency is it in?

Market capitalization is calculated by multiplying Illumina's share price by its total shares outstanding. Although Illumina reports its financial statements in USD, market cap on this page is shown in US dollars (USD) for comparability with other companies.

What is the highest market cap Illumina has reached?

Illumina (ILMN) reached its all-time high market cap of $74.98B on August 16, 2021, based on daily closing values in our history.

What is the lowest market cap Illumina has reached?

Illumina (ILMN) recorded its all-time low market cap of $54.35M on March 13, 2003 in the available daily history.

Is Illumina's market cap above or below its 5-year average?

At $25.70B, Illumina's market cap is currently below its five-year average of $29.28B.

What was Illumina's market cap in 2025?

Illumina (ILMN) ended 2025 with a market cap of $21.05B.

What was Illumina's market cap in 2026?

Illumina (ILMN) ended 2026 with a market cap of $25.70B.

Illumina (ILMN) Market Cap History

Current

$25.70B

As of Jun 15, 2026

5-Year Average

$29.28B

All-Time High

$74.98B

Aug 16, 2021

All-Time Low

$54.35M

Mar 13, 2003

Market cap daily chart for Illumina (ILMN)

Jun 16, 2021 – Jun 15, 2026 · 1,255 trading days

Market Cap growth chart for Illumina (ILMN) from 2000 to 2026

Latest: +22.1%

Market Cap history table for Illumina (ILMN) from 2000 to 2026


2026	$25.70B	+22.1%	+$4.65B	Jun 15, 2026	May 4, 2026
2025	$21.05B	-2.1%	−$455.73M	Dec 28, 2025	Feb 12, 2026
2024	$21.51B	+0.6%	+$127.37M	Dec 29, 2024	Feb 12, 2025
2023	$21.38B	-61.7%	−$34.45B	Dec 31, 2023	Feb 16, 2024
2023	$30.85B	-44.7%	−$24.98B	Jan 1, 2023	Feb 17, 2023
2022	$55.83B	+4.9%	+$2.61B	Jan 2, 2022	Feb 18, 2022
2021	$53.22B	—	—	Jan 3, 2021	Feb 17, 2021
2019	$48.12B	+10.8%	+$4.69B	Dec 29, 2019	Feb 11, 2020
2018	$43.43B	+38.2%	+$12.00B	Dec 31, 2018	Feb 12, 2019
2017	$31.43B	+70.7%	+$13.01B	Dec 31, 2017	Feb 13, 2018
2016	$18.42B	-33.7%	−$9.38B	Dec 31, 2016	Feb 14, 2017
2015	$27.79B	+4.0%	+$1.07B	Dec 31, 2015	Mar 2, 2016
2014	$26.72B	+77.7%	+$11.68B	Dec 31, 2014	Feb 18, 2015
2013	$15.04B	+108.3%	+$7.82B	Dec 31, 2013	Feb 18, 2014
2012	$7.22B	+75.5%	+$3.11B	Dec 31, 2012	Feb 15, 2013
2011	$4.12B	-53.4%	−$4.71B	Dec 31, 2011	Feb 24, 2012
2010	$8.83B	+116.0%	+$4.74B	Dec 31, 2010	Feb 28, 2011
2009	$4.09B	+20.8%	+$705.27M	Dec 31, 2009	Feb 26, 2010
2008	$3.38B	+8.5%	+$263.66M	Dec 31, 2008	Feb 26, 2009
2007	$3.12B	+67.5%	+$1.26B	Dec 31, 2007	Feb 26, 2008
2006	$1.86B	+238.6%	+$1.31B	Dec 31, 2006	Feb 28, 2007
2005	$550.01M	+66.4%	+$219.52M	Dec 31, 2005	Mar 6, 2006
2004	$330.49M	+50.9%	+$111.49M	Dec 31, 2004	Mar 8, 2005
2003	$219.01M	+116.2%	+$117.69M	Dec 31, 2003	Mar 12, 2004
2002	$101.32M	-70.2%	−$238.40M	Dec 31, 2002	Mar 27, 2003
2001	$339.72M	-21.8%	−$94.76M	Dec 31, 2001	Mar 29, 2002
2000	$434.49M	—	—	Dec 31, 2000	Mar 29, 2001

2026$25.70B+22.1%
2025$21.05B-2.1%
2024$21.51B+0.6%
2023$21.38B-61.7%
2023$30.85B-44.7%
2022$55.83B+4.9%
2021$53.22B—
2019$48.12B+10.8%
2018$43.43B+38.2%
2017$31.43B+70.7%
2016$18.42B-33.7%
2015$27.79B+4.0%
2014$26.72B+77.7%
2013$15.04B+108.3%
2012$7.22B+75.5%
2011$4.12B-53.4%
2010$8.83B+116.0%
2009$4.09B+20.8%
2008$3.38B+8.5%
2007$3.12B+67.5%
2006$1.86B+238.6%
2005$550.01M+66.4%
2004$330.49M+50.9%
2003$219.01M+116.2%
2002$101.32M-70.2%
2001$339.72M-21.8%
2000$434.49M—

Market Cap values are taken from Illumina's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Market Cap at Illumina (ILMN)

According to Illumina's latest reported financial statements, the company's latest reported market cap is $18.12B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).

Headline figure above is from the reporting period ending March 29, 2026 (reported May 4, 2026). Chart and table below cover the full reported history back to 2000.

As of the 2026 fiscal year, Illumina (ILMN) reported market cap of $25.70B – grew 22.1% year-over-year.

Across 2022–2026 (5 years), Illumina market cap produced a CAGR of -13.5% – with a net decline across the window.

Between 2022 and 2026, Illumina market cap plunged 54.0%, falling from $55.83B to $25.70B.

Across the available history, market cap reached its high of $55.83B in 2022 and its low of $101.32M in 2002.

Illumina Market Cap by Year

Illumina Market Cap 2026: $25.70B

Illumina posted market cap of $25.70B in 2026, grew 22.1% from 2025.

Illumina Market Cap 2025: $21.05B

In 2025, Illumina reported market cap of $21.05B, edged down 2.1% below 2024.

Illumina Market Cap 2024: $21.51B

Illumina market cap in 2024 was $21.51B, edged up 0.6% from 2023.

Illumina Market Cap 2023: $21.38B

2023's market cap for Illumina came in at $21.38B, plunged 30.7% below 2023.

Illumina Market Cap 2023: $30.85B

Illumina market cap in 2023 was $30.85B.

See more financial history for Illumina (ILMN).

Sector peers by Market Cap

Healthcare peers of Illumina (ILMN), ranked by their latest market cap


Eli Lilly (LLY)	$1.06T
Johnson & Johnson (JNJ)	$567.28B
AbbVie (ABBV)	$391.50B
UnitedHealth Group (UNH)	$373.28B
Merck & Co. (MRK)	$283.78B
AstraZeneca (AZN)	$274.92B
Novo Nordisk (NVO)	$195.17B
Amgen (AMGN)	$189.18B

Frequently asked questions

Illumina (ILMN) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview

ILMN Overview

Counters

Income Statement

Cash Flow

Capital Return

Forecast & Valuation